Clarivate and Elsevier have recently released the 2024 Journal Citation Reports(JCR)and CiteScore,respectively.We are delighted to share the exciting news that Chinese Medicine and Culture(CMC)has achieved its first i...Clarivate and Elsevier have recently released the 2024 Journal Citation Reports(JCR)and CiteScore,respectively.We are delighted to share the exciting news that Chinese Medicine and Culture(CMC)has achieved its first impact factor(IF)of 0.5!It ranks in Q2 in the category of History&Philosophy of Science,and in Q4 in the category of Integrative&Complementary Medicine,marking a major breakthrough!展开更多
On 20 June 2019, Clarivate Analytics (2019) announced its Journal Citation Reports of 2018. From this, Zoological Research (ZR) received its first impact factor based on citations in 2018 for indexed papers published ...On 20 June 2019, Clarivate Analytics (2019) announced its Journal Citation Reports of 2018. From this, Zoological Research (ZR) received its first impact factor based on citations in 2018 for indexed papers published during 2016 to 2017.展开更多
Announcing 2024 Impact Factor for Acta Pharmaceutica Sinica B.Acta Pharmaceutica Sinica B(APSB)is delighted to announce that the 2024 Journal Impact Factor(JIF)of APSB is now 14.6(13.8 without self-citations)according...Announcing 2024 Impact Factor for Acta Pharmaceutica Sinica B.Acta Pharmaceutica Sinica B(APSB)is delighted to announce that the 2024 Journal Impact Factor(JIF)of APSB is now 14.6(13.8 without self-citations)according to the latest Clarivate Journal Citation Reports released on Jun 18th,2025.APSB ranks No.6(Q1 quartile)of the 352 journals in the Pharmacology and Pharmacy category.展开更多
Announcing 2024 Impact Factor for Acta Pharmaceutica Sinica B Acta Pharmaceutica Sinica B(APsB)is delighted to announce that the 2024 Journal Impact Factor(JIF)of APSB is now 14.6(13.8 without self-citations)according...Announcing 2024 Impact Factor for Acta Pharmaceutica Sinica B Acta Pharmaceutica Sinica B(APsB)is delighted to announce that the 2024 Journal Impact Factor(JIF)of APSB is now 14.6(13.8 without self-citations)according to the latest Clarivate Journal Citation Reports released on Jun 18th,2025.APSB ranks No.6(Q1 quartile)of the 352 journals in the Pharmacology and Pharmacy category.展开更多
Announcing 2024 Impact Factor for Acta Pharmaceutica Sinica B Acta Pharmaceutica Sinica B(APSB)is delighted to announce that the 2024 Journal Impact Factor(JIF)of APSB is now 14.6(13.8 without self-citations)according...Announcing 2024 Impact Factor for Acta Pharmaceutica Sinica B Acta Pharmaceutica Sinica B(APSB)is delighted to announce that the 2024 Journal Impact Factor(JIF)of APSB is now 14.6(13.8 without self-citations)according to the latest Clarivate Journal Citation Reports released on Jun 18th,2025.APSB ranks No.6(Q1 quartile)of the 352 journals in the Pharmacology and Pharmacy category.展开更多
Acta Pharmaceutica Sinica B(APSB)is delighted to announce that the 2024 Journal Impact Factor(JIF)of APSB is now 14.6(13.8 without self-citations)according to the latest Clarivate Journal Citation Reports released on ...Acta Pharmaceutica Sinica B(APSB)is delighted to announce that the 2024 Journal Impact Factor(JIF)of APSB is now 14.6(13.8 without self-citations)according to the latest Clarivate Journal Citation Reports released on Jun 18th,2025.APSB ranks No.6(Q1 quartile)of the 352 journals in the Pharmacology and Pharmacy category.展开更多
Announcing 2024 Impact Factor for Acta Pharmaceutica Sinica B.Acta Pharmaceutica Sinica B(APSB)is delighted to announce that the 2024 Journal Impact Factor(JIF)of APSB is now 14.6(13.8 without self-citations)according...Announcing 2024 Impact Factor for Acta Pharmaceutica Sinica B.Acta Pharmaceutica Sinica B(APSB)is delighted to announce that the 2024 Journal Impact Factor(JIF)of APSB is now 14.6(13.8 without self-citations)according to the latest Clarivate Journal Citation Reports released on Jun 18^(th),2025.APSB ranks No.6(Q1 quartile)of the 352 journals in the Pharmacology and Pharmacy category.展开更多
1.About the journal Chinese Herbal Medicines(CHM)is an official international journal sponsored by Tianjin Institute of Pharmaceutical Research and Institute of Medicinal Plant Development,Chinese Academy of Medical S...1.About the journal Chinese Herbal Medicines(CHM)is an official international journal sponsored by Tianjin Institute of Pharmaceutical Research and Institute of Medicinal Plant Development,Chinese Academy of Medical Sciences.The journal is included in the following databases:ESCI,Pub Med Central,Scopus,etc.On June 20th,2024,Clarivate Analytics released the Journal Citation Reports for 2023.CHM received Journal Impact Factor4.7,ranking in Q1 in Chemistry,Medicinal category.展开更多
Announcing 2024 Impact Factor for Acta Pharmaceutica Sinica B Acta Pharmaceutica Sinica B(APSB)is delighted to announce that the 2024 Journal Impact Factor(JIF)of APSB is now 14.6(13.8 without self-citations)according...Announcing 2024 Impact Factor for Acta Pharmaceutica Sinica B Acta Pharmaceutica Sinica B(APSB)is delighted to announce that the 2024 Journal Impact Factor(JIF)of APSB is now 14.6(13.8 without self-citations)according to the latest Clarivate Journal Citation Reports released on Jun 18^(th),2025.展开更多
文摘Clarivate and Elsevier have recently released the 2024 Journal Citation Reports(JCR)and CiteScore,respectively.We are delighted to share the exciting news that Chinese Medicine and Culture(CMC)has achieved its first impact factor(IF)of 0.5!It ranks in Q2 in the category of History&Philosophy of Science,and in Q4 in the category of Integrative&Complementary Medicine,marking a major breakthrough!
文摘On 20 June 2019, Clarivate Analytics (2019) announced its Journal Citation Reports of 2018. From this, Zoological Research (ZR) received its first impact factor based on citations in 2018 for indexed papers published during 2016 to 2017.
文摘Announcing 2024 Impact Factor for Acta Pharmaceutica Sinica B.Acta Pharmaceutica Sinica B(APSB)is delighted to announce that the 2024 Journal Impact Factor(JIF)of APSB is now 14.6(13.8 without self-citations)according to the latest Clarivate Journal Citation Reports released on Jun 18th,2025.APSB ranks No.6(Q1 quartile)of the 352 journals in the Pharmacology and Pharmacy category.
文摘Announcing 2024 Impact Factor for Acta Pharmaceutica Sinica B Acta Pharmaceutica Sinica B(APsB)is delighted to announce that the 2024 Journal Impact Factor(JIF)of APSB is now 14.6(13.8 without self-citations)according to the latest Clarivate Journal Citation Reports released on Jun 18th,2025.APSB ranks No.6(Q1 quartile)of the 352 journals in the Pharmacology and Pharmacy category.
文摘Announcing 2024 Impact Factor for Acta Pharmaceutica Sinica B Acta Pharmaceutica Sinica B(APSB)is delighted to announce that the 2024 Journal Impact Factor(JIF)of APSB is now 14.6(13.8 without self-citations)according to the latest Clarivate Journal Citation Reports released on Jun 18th,2025.APSB ranks No.6(Q1 quartile)of the 352 journals in the Pharmacology and Pharmacy category.
文摘Acta Pharmaceutica Sinica B(APSB)is delighted to announce that the 2024 Journal Impact Factor(JIF)of APSB is now 14.6(13.8 without self-citations)according to the latest Clarivate Journal Citation Reports released on Jun 18th,2025.APSB ranks No.6(Q1 quartile)of the 352 journals in the Pharmacology and Pharmacy category.
文摘Announcing 2024 Impact Factor for Acta Pharmaceutica Sinica B.Acta Pharmaceutica Sinica B(APSB)is delighted to announce that the 2024 Journal Impact Factor(JIF)of APSB is now 14.6(13.8 without self-citations)according to the latest Clarivate Journal Citation Reports released on Jun 18^(th),2025.APSB ranks No.6(Q1 quartile)of the 352 journals in the Pharmacology and Pharmacy category.
文摘1.About the journal Chinese Herbal Medicines(CHM)is an official international journal sponsored by Tianjin Institute of Pharmaceutical Research and Institute of Medicinal Plant Development,Chinese Academy of Medical Sciences.The journal is included in the following databases:ESCI,Pub Med Central,Scopus,etc.On June 20th,2024,Clarivate Analytics released the Journal Citation Reports for 2023.CHM received Journal Impact Factor4.7,ranking in Q1 in Chemistry,Medicinal category.
文摘Announcing 2024 Impact Factor for Acta Pharmaceutica Sinica B Acta Pharmaceutica Sinica B(APSB)is delighted to announce that the 2024 Journal Impact Factor(JIF)of APSB is now 14.6(13.8 without self-citations)according to the latest Clarivate Journal Citation Reports released on Jun 18^(th),2025.
